Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 SALES VALUE AND VOLUME
2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PESTAL ANALYSIS
5.2 PORTER’S FIVE FORCES
5.3 KEY STRATEGIC INITIATIVES
5.4 TECHNOLOGICAL INOVATIONS
6 INDUSTRY INSIGHTS
7 REGULATORY FRAMWORK
8 NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 CLASS I BIOLOGICAL SAFETY CABINET (BSC)
8.2.1 MARKET VALUE (USD MN)
8.2.2 MARKET VOLUME (UNITS)
8.2.3 AVERAGE SELLINF PRICE (USD)
8.3 CLASS II BIOLOGICAL SAFETY CABINET (BSC)
8.3.1 CLASS II TYPE A
8.3.1.1. CLASS II TYPE A1
8.3.1.1.1. MARKET VALUE (USD MN)
8.3.1.1.2. MARKET VOLUME (UNITS)
8.3.1.1.3. AVERAGE SELLINF PRICE (USD)
8.3.1.2. CLASS II TYPE A2
8.3.1.2.1. MARKET VALUE (USD MN)
8.3.1.2.2. MARKET VOLUME (UNITS)
8.3.1.2.3. AVERAGE SELLINF PRICE (USD)
8.3.2 CLASS II TYPE B
8.3.2.1. CLASS II TYPE B1
8.3.2.1.1. MARKET VALUE (USD MN)
8.3.2.1.2. MARKET VOLUME (UNITS)
8.3.2.1.3. AVERAGE SELLINF PRICE (USD)
8.3.2.2. CLASS II TYPE B2
8.3.2.2.1. MARKET VALUE (USD MN)
8.3.2.2.2. MARKET VOLUME (UNITS)
8.3.2.2.3. AVERAGE SELLINF PRICE (USD)
8.4 CLASS III BIOLOGICAL SAFETY CABINET (BSC)
8.4.1 MARKET VALUE (USD MN)
8.4.2 MARKET VOLUME (UNITS)
8.4.3 AVERAGE SELLINF PRICE (USD)
9 NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET, BY MATERIAL
9.1 OVERVIEW
9.2 INDUSTRIAL
9.2.1 CLASS I BIOLOGICAL SAFETY CABINET
9.2.2 CLASS II BIOLOGICAL SAFETY CABINET (BSC)
9.2.3 CLASS III BIOLOGICAL SAFETY CABINET (BSC)
9.3 ACADEMIC
9.3.1 CLASS I BIOLOGICAL SAFETY CABINET
9.3.2 CLASS II BIOLOGICAL SAFETY CABINET (BSC)
9.3.3 CLASS III BIOLOGICAL SAFETY CABINET (BSC)
9.4 RESEARCH
9.4.1 CLASS I BIOLOGICAL SAFETY CABINET
9.4.2 CLASS II BIOLOGICAL SAFETY CABINET (BSC)
9.4.3 CLASS III BIOLOGICAL SAFETY CABINET (BSC)
10 NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET, BY END USER
10.1 OVERVIEW
10.2 ACADEMIC & RESEARCH INSTITUTIONS
10.3 DIAGNOSTIC AND TESTING LABORATORIES
10.4 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
10.5 OTHERS
11 NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 RETAIL SALES
11.4 ONLINE SALES
11.5 OTHERS
12 NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET, BY GEOGRAPHY
NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
12.1 NORTH AMERICA
12.1.1 U.S.
12.1.1.1. U.S. BIOLOGICAL SAFETY CABINET MARKET, BY PRODUCT TYPE
12.1.1.2. U.S. BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION
12.1.1.3. U.S. BIOLOGICAL SAFETY CABINET MARKET, BY END USER
12.1.1.4. U.S. BIOLOGICAL SAFETY CABINET MARKET, BY DISTRIBUTION CHANNEL
12.1.2 CANADA
12.1.3 MEXICO
12.2 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
13 NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET, SWOT AND DBMR ANALYSIS
14 NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET, COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
14.2 MERGERS & ACQUISITIONS
14.3 NEW PRODUCT DEVELOPMENT & APPROVALS
14.4 EXPANSIONS
14.5 REGULATORY CHANGES
14.6 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
15 NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET, COMPANY PROFILE
15.1 ESCO MICRO PTE LTD.
15.1.1 COMPANY OVERVIEW
15.1.2 REVENUE ANALYSIS
15.1.3 GEOGRAPHIC PRESENCE
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENTS
15.2 NUAIRE
15.2.1 COMPANY OVERVIEW
15.2.2 REVENUE ANALYSIS
15.2.3 GEOGRAPHIC PRESENCE
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENTS
15.3 THERMO FISHER SCIENTIFIC
15.3.1 COMPANY OVERVIEW
15.3.2 REVENUE ANALYSIS
15.3.3 GEOGRAPHIC PRESENCE
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENTS
15.4 AIRCLEAN SYSTEMS, INC.
15.4.1 COMPANY OVERVIEW
15.4.2 REVENUE ANALYSIS
15.4.3 GEOGRAPHIC PRESENCE
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENTS
15.5 STERICOX INDIA PRIVATE LIMITED
15.5.1 COMPANY OVERVIEW
15.5.2 REVENUE ANALYSIS
15.5.3 GEOGRAPHIC PRESENCE
15.5.4 PRODUCT PORTFOLIO
15.5.5 RECENT DEVELOPMENTS
15.6 LABCONCO
15.6.1 COMPANY OVERVIEW
15.6.2 REVENUE ANALYSIS
15.6.3 GEOGRAPHIC PRESENCE
15.6.4 PRODUCT PORTFOLIO
15.6.5 RECENT DEVELOPMENTS
15.7 BAKER
15.7.1 COMPANY OVERVIEW
15.7.2 REVENUE ANALYSIS
15.7.3 GEOGRAPHIC PRESENCE
15.7.4 PRODUCT PORTFOLIO
15.7.5 RECENT DEVELOPMENTS
15.8 BIGNEAT LTD.
15.8.1 COMPANY OVERVIEW
15.8.2 REVENUE ANALYSIS
15.8.3 GEOGRAPHIC PRESENCE
15.8.4 PRODUCT PORTFOLIO
15.8.5 RECENT DEVELOPMENTS
15.9 TERRA UNIVERSAL. INC.
15.9.1 COMPANY OVERVIEW
15.9.2 REVENUE ANALYSIS
15.9.3 GEOGRAPHIC PRESENCE
15.9.4 PRODUCT PORTFOLIO
15.9.5 RECENT DEVELOPMENTS
15.1 KEWAUNEE INTERNATIONAL GROUP
15.10.1 COMPANY OVERVIEW
15.10.2 REVENUE ANALYSIS
15.10.3 GEOGRAPHIC PRESENCE
15.10.4 PRODUCT PORTFOLIO
15.10.5 RECENT DEVELOPMENTS
15.11 GERMFREE LABORATORIES, INC.
15.11.1 COMPANY OVERVIEW
15.11.2 REVENUE ANALYSIS
15.11.3 GEOGRAPHIC PRESENCE
15.11.4 PRODUCT PORTFOLIO
15.11.5 RECENT DEVELOPMENTS
15.12 TELSTAR (AZBIL GROUP)
15.12.1 COMPANY OVERVIEW
15.12.2 REVENUE ANALYSIS
15.12.3 GEOGRAPHIC PRESENCE
15.12.4 PRODUCT PORTFOLIO
15.12.5 RECENT DEVELOPMENTS
15.13 TOPAIR SYSTEMS
15.13.1 COMPANY OVERVIEW
15.13.2 REVENUE ANALYSIS
15.13.3 GEOGRAPHIC PRESENCE
15.13.4 PRODUCT PORTFOLIO
15.13.5 RECENT DEVELOPMENTS
15.14 IGENE LABSERVE PRIVATE LIMITED
15.14.1 COMPANY OVERVIEW
15.14.2 REVENUE ANALYSIS
15.14.3 GEOGRAPHIC PRESENCE
15.14.4 PRODUCT PORTFOLIO
15.14.5 RECENT DEVELOPMENTS
15.15 BIONICS SCIENTIFIC TECHNOLOGIES (P) LTD.
15.15.1 COMPANY OVERVIEW
15.15.2 REVENUE ANALYSIS
15.15.3 GEOGRAPHIC PRESENCE
15.15.4 PRODUCT PORTFOLIO
15.15.5 RECENT DEVELOPMENTS
15.16 STERILE TECH INDIA
15.16.1 COMPANY OVERVIEW
15.16.2 REVENUE ANALYSIS
15.16.3 GEOGRAPHIC PRESENCE
15.16.4 PRODUCT PORTFOLIO
15.16.5 RECENT DEVELOPMENTS
15.17 ALPHA LINEAR
15.17.1 COMPANY OVERVIEW
15.17.2 REVENUE ANALYSIS
15.17.3 GEOGRAPHIC PRESENCE
15.17.4 PRODUCT PORTFOLIO
15.17.5 RECENT DEVELOPMENTS
15.18 SKAN AG
15.18.1 COMPANY OVERVIEW
15.18.2 REVENUE ANALYSIS
15.18.3 GEOGRAPHIC PRESENCE
15.18.4 PRODUCT PORTFOLIO
15.18.5 RECENT DEVELOPMENTS
15.19 PHC CORPORATION
15.19.1 COMPANY OVERVIEW
15.19.2 REVENUE ANALYSIS
15.19.3 GEOGRAPHIC PRESENCE
15.19.4 PRODUCT PORTFOLIO
15.19.5 RECENT DEVELOPMENTS
15.2 ENVIRCO
15.20.1 COMPANY OVERVIEW
15.20.2 REVENUE ANALYSIS
15.20.3 GEOGRAPHIC PRESENCE
15.20.4 PRODUCT PORTFOLIO
15.20.5 RECENT DEVELOPMENTS
15.21 HAMILTON HEALTH SCIENCES
15.21.1 COMPANY OVERVIEW
15.21.2 REVENUE ANALYSIS
15.21.3 GEOGRAPHIC PRESENCE
15.21.4 PRODUCT PORTFOLIO
15.21.5 RECENT DEVELOPMENTS
15.22 LABOGENE
15.22.1 COMPANY OVERVIEW
15.22.2 REVENUE ANALYSIS
15.22.3 GEOGRAPHIC PRESENCE
15.22.4 PRODUCT PORTFOLIO
15.22.5 RECENT DEVELOPMENTS
15.23 CRUMA
15.23.1 COMPANY OVERVIEW
15.23.2 REVENUE ANALYSIS
15.23.3 GEOGRAPHIC PRESENCE
15.23.4 PRODUCT PORTFOLIO
15.23.5 RECENT DEVELOPMENTS
*NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST Conclusion
16 RELATED REPORTS
17 CONCLUSION
18 QUESTIONNAIRE
19 ABOUT DATA BRIDGE MARKET RESEARCH
